Published articles and reports in Toxicology & Pathology
[1] Wei C I, Al‑Bayati MA, Culbertson M R, Rosenblatt, LS, and Hansen L D. Acute toxicity of ammonium metavanadate in mice. Journal of Toxicology and Environmental Health 10: 673‑687,1982.
[2] Raabe OG, Al‑Bayati MA, Gielow F, Schreider JP, and Parks NJ. Studies of the distribution in beagles of Pu‑241 after intratracheal instillation of ultrafine insoluble particles. Health Physics 47:210, 1984.
[3] Knaak JB, Schreider J, Raabe OG, Al‑Bayati MA, and Wilson BW. The percutaneous absorption of oxidazan in the adult female rat. In: Pesticide Science and Biotechnology. Greenhalgn, R. and Roberts, T. R. (eds.), Blackwell Scientific Publications, pp. 545‑548, 1987.
[4] Knaak JB, Al‑Bayati MA, Gielow F, and Raabe OG. Safety related to exposure: Dermal dose‑red cell cholinesterase response curves for Ethoprop and Mocap 6 EC. Bulletin of Environmental Contamination Toxicology 38: 834‑839, 1987. Springer‑Verlag New York Inc.
[5] Raabe OG and Al-Bayati, MA. Gastrointestinal-tract Uptake of Benzene in drinking water in rats. Report submitted to the University of California Toxic Substance and Teaching Program, Davis, CA. 1987.
[6] Raabe OG, Al-Bayati MA, Gielow F, and Uyeminami D. Inhalation Uptake of xenobiotics vapors by people. Report submitted to Air Resources Board, Sacramento CA, March 1988.
[7] Raabe OG, Knaak JB , Al-Bayati MA, Uyeminami D, and Gielow F. Development of Multiple Route Compound Pharmacokinetic Models: Development of a physiological Pharmacokinetic Model for an Organophosphate: isofenphos. Submitted to Exposure Assessment group, USEPA, Washington, DC. September 20, 1988.
[8] Raabe OG, Al-Bayati MA, Gielow F, Teague S, and Uyeminami D. Inhalation Uptake of Xenobiotic Vapors by People. Report submitted to the Biological effects Research Section, California Air Resources Board, Sacramento, California (CARB Contract NO. A5-155-33). March 1988.
[9] Raabe O G, Al‑Bayati MA, Teague S, and Rasolt A. Regional deposition of inhaled monodisperse coarse and fine particles in small laboratory animals. Annals of Occupational Hygiene 32(1): 53‑63, 1988.
[10] Knaak JB, Al‑Bayati MA, Raabe OG, Wiedmann JL, Pensyl JW, Ross JH, Leber AP, and Jones P. Mixer‑loader‑applicator exposure and percutaneous absorption studies involving EPTC herbicide. Chapter 22. In: Biological Monitoring for Pesticide Exposure: Measurement, Estimation, and Risk Reduction, Wang, RGM, Franklin CA, Honeycut RC, and Reinert JC (eds.), American Chemical Society, Washington, DC., pp. 288‑303, 1989.
[11] Al‑Bayati, MA, Giri SN, Raabe OG, Rosenblatt LS, and Shifrine M. Time and dose‑response study of the effects of vanadate on rats: Morphological and Biochemical changes in organs. Journal of Environmental Pathology, Toxicology and Oncology 9(5): 435‑455, 1989.
[12] Al‑Bayati MA, Giri SN, and Raabe OG. Time and dose‑response study of the effects of vanadate on rats: Changes in blood cells and serum elements. Journal of Environmental Pathology, Toxicology, and Oncology 10(4‑5): 206‑213, 1990.
[13] Knaak JB, Al‑Bayati MA, Raabe OG, and Blancato JN. In vivo percutaneous absorption studies in rat: Pharmacokinetics and modeling of isofenphos absorption. In: Prediction of Percutaneous Penetration: Methods, Measurements, and Modelling. Scott,
R. C. (ed), IBC Technical, England, 1990.
[14] Al‑Bayati MA, Raabe OG, Giri SN, and Knaak JB. Distribution of vanadate in rat following subcutaneous and oral exposure. Journal of the American College of Toxicology 10 (2): 233‑241, 1991.
[15] Al‑Bayati MA, Culbertson MR, Schreider JP, Rosenblatt LS, and Raabe OG. The lymphotoxic action of vanadate. Journal of Environmental Pathology, Toxicology, and Oncology, Volume II, No.2, 1992.
[16] Knaak JB, Al‑Bayati MA, and Raabe OG. Physiologically‑based pharmacokinetics modeling to predict tissue dose and cholinesterase inhibition in workers exposed to organophosphorus and carbamate pesticides. In: Health Risk Assessment Through Dermal and Inhalation Exposure and Absorption of Toxicant.Wang GM, Knaak JB, and Maibach HI (eds.). CRC Press, Boca Raton, FL, 1992.
[17] Al-Bayati MA, Raabe OG, and Teague SV. Effect of inhaled dimethylselenide in the Fischer 344 male rat. Journal of Toxicology and Environmental Health 37:549-557.
[18] Raabe OG, Al-Bayati MA, Shulec PD, Gielow F, Uyeminami D, and Shimasaki N. Dermal Absorption of Methanol and methanol/Gasoline Mixtures. Report submitted to the Biological effects Research Section, California Air Resources Board, Sacramento, California (CARB Contract NO. A933-186). December 1992.
[19] Raabe OG, Al-Bayati MA, Shulec PD, Gielow F, Uyeminami D, and Shimasaki N. Dermal absorption of methanol and methanol/gasoline mixtures. Report submitted to Air Resources Board, Sacramento CA, December 1992.
[20] Knaak JB, Al‑Bayati MA, Raabe OG, Blancato JN. Development of in vitro Vmax and Km values for the metabolism of isofenphos by P-450 liver enzymes in animals and human. Toxicology and Applied Pharmacology 120:106-113, 1993.
[21] Gospe SM and Al‑Bayati MA Comparison of oral and inhalation exposures to toluene. American College of Toxicology, 13(1): 21-32, 1993.
[22] Raabe OG, Wilson DW, Al-Bayati MA, Hornof WJ, and Rosenblatt LS. Biological effects of inhaled pollutant aerosols. Ann. Occup. Hyg. Vol. 38 Supplement 1. pp. 323-330, 1994.
[23] Knaak JB, Al‑Bayati MA, Raabe OG, and Blancato JN. Prediction of anticholinesterase activity and urinary metabolites of isofenphos: Use of apercutaneous physiologically based pharmacokinetic-physiologically based pharmacodynamic model. In: Biomarkers of Human Exposure to Pesticides, Chapter 17, Saleh, MA, Blancato, JN, and Nauman, CH (eds.). American Chemical Society Symposium Series 542, Washington, D.C.1994.
[24] Knaak JB, Al‑Bayati MA, and Raabe OG. Development of partition coefficients, Vmax and Km values, and allometric relationships. Toxicology letters 79, 87-98, 1995.
[25] Knaak JB, Al‑Bayati MA, Raabe OG, and Blancato JN. Use of a multiple pathway and multiroute PBPK model for predicting OP toxicity: In American Chemical Society Symposium: Field Application of Biomarkers for Agrochemicals. April 3-7, Anaheim, CA. 1995.
[26] Knaak JB, Al‑Bayati MA, Raabe OG, and Blancato JN. Use of a multiple pathway and multiroute PBPK model for predicting OP toxicity: Field Application of Biomarkers for Agrochemicals. In American Chemical Society Symposium Series 643, Washington, D.C., pp.206-228, 1996.
[27] Raabe OG and Al-Bayati MA. Distribution and retention of inhaled vanadium on inert airborne particles. Ann. Occup. Hyg., Vol.41, supplement 1., 1996.
[28] Al-Bayati MA, Yan Xie, F. Charles Mohr, Solomon B. Margolin, Shri N. Giri. Effect of Pirfenidone Aganist Vanadate-Induced Kidney Fibrosis in Rats. Biochemical Pharmacology 64:517-522, 2002.
[29] Giri SN, Al-Bayati MA, Du X, Schelegle E, Mohr FC, Margolin SB. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats. Cancer Chemother Pharmacol. 2004 Feb; 53(2): 141-50, 2004.
[30] Al-Bayati MA. Examining the causes of AIDS. Medical Veritas; 3 (1): 900-913, 2006.